UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial

Blood, 2017-06, Vol.129 (25), p.3304-3313

2017

Volltextzugriff (PDF)

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

Blood, 2011-12, Vol.118 (26), p.6752-6759

2011

Volltextzugriff (PDF)

Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial

Blood, 2010-04, Vol.115 (14), p.2740-2748

2010

Volltextzugriff (PDF)

Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome: Current Status of Clinical Applications and Future Directions

Molecular diagnosis & therapy, 2013-02, Vol.17 (1), p.31-47

2013

Volltextzugriff (PDF)

Favorable Survival Maintained in Children Who Have Myeloid Leukemia Associated With Down Syndrome Using Reduced-Dose Chemotherapy on Children's Oncology Group Trial A2971: A Report From the Children's Oncology Group

Cancer, 2012-10, Vol.118 (19), p.4806-4814

2012

Volltextzugriff (PDF)

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced‐dose chemotherapy on Children's Oncology Group trial A2971

Cancer, 2012-10, Vol.118 (19), p.4806-4814

2012

Volltextzugriff (PDF)

The VWRPY Domain Is Essential for RUNX1 Function in Hematopoietic Progenitor Cell Maturation and Megakaryocyte Differentiation

Blood, 2018-11, Vol.132 (Supplement 1), p.1319-1319

2018

Volltextzugriff (PDF)

Unraveling a Novel Mechanism of RUNX1 Activity in Familial Platelet Disorder with Associated Myeloid Malignancy

Blood, 2016-12, Vol.128 (22), p.2693-2693

2016

Volltextzugriff (PDF)

Expanded Phenotypic and Genetic Heterogeneity in the Clinical Spectrum of FPD-AML: Lymphoid Malignancies and Skin Disorders Are Common Features in Carriers of Germline RUNX1 Mutations

Blood, 2016-12, Vol.128 (22), p.1212-1212

2016

Volltextzugriff (PDF)

Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial

Blood, 2014-12, Vol.124 (21), p.278-278

2014

Volltextzugriff (PDF)

TP53 Testing and Li-Fraumeni Syndrome: Current Status of Clinical Applications and Future Directions

Molecular diagnosis & therapy, 2013-02, Vol.17 (1), p.31-47

2013

Volltextzugriff (PDF)

The role of GIP and pancreatic GLP-1 in the glucoregulatory effect of DPP-4 inhibition in mice

Diabetologia, 2019-10, Vol.62 (10), p.1928-1937

2019

Volltextzugriff (PDF)

Sexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasis

American journal of physiology: endocrinology and metabolism, 2008-03, Vol.294 (3), p.E630-E639

2008

Volltextzugriff (PDF)

MGAT2 deficiency and vertical sleeve gastrectomy have independent metabolic effects in the mouse

American journal of physiology: endocrinology and metabolism, 2014-12, Vol.307 (11), p.E1065-E1072

2014

Volltextzugriff (PDF)

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome

Blood, 2007-08, Vol.110 (3), p.1077-1079

2007

Volltextzugriff (PDF)

Sexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasis

American journal of physiology: endocrinology and metabolism, 2008, Vol.57 (3)

2008

Volltextzugriff (PDF)

A treatable cause of ataxia in children

Pediatric neurology, 2001-02, Vol.24 (2), p.135-138

2001

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(16)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(18)

Sprache

Englisch
(18)

Erscheinungsjahr

n.n

Zeitschrift / Serie

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial

Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971

Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial

Tumor Protein p53 (TP53) Testing and Li-Fraumeni Syndrome: Current Status of Clinical Applications and Future Directions

Favorable Survival Maintained in Children Who Have Myeloid Leukemia Associated With Down Syndrome Using Reduced-Dose Chemotherapy on Children's Oncology Group Trial A2971: A Report From the Children's Oncology Group

Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group

Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced‐dose chemotherapy on Children's Oncology Group trial A2971

The VWRPY Domain Is Essential for RUNX1 Function in Hematopoietic Progenitor Cell Maturation and Megakaryocyte Differentiation

Unraveling a Novel Mechanism of RUNX1 Activity in Familial Platelet Disorder with Associated Myeloid Malignancy

Expanded Phenotypic and Genetic Heterogeneity in the Clinical Spectrum of FPD-AML: Lymphoid Malignancies and Skin Disorders Are Common Features in Carriers of Germline RUNX1 Mutations

Improvement in Treatment Outcome and Identification of a New Prognostic Parameter in Down Syndrome Acute Myeloid Leukemia (DS-AML): Results of the Children’s Oncology Group (COG) Phase III AAML0431 Trial

TP53 Testing and Li-Fraumeni Syndrome: Current Status of Clinical Applications and Future Directions

The role of GIP and pancreatic GLP-1 in the glucoregulatory effect of DPP-4 inhibition in mice

Sexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasis

MGAT2 deficiency and vertical sleeve gastrectomy have independent metabolic effects in the mouse

Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome

Sexually different actions of leptin in proopiomelanocortin neurons to regulate glucose homeostasis

A treatable cause of ataxia in children

Suchergebnisse filtern